Shares of Made.com rallied on Tuesday after Davy upgraded its stance on the furniture retailer to ‘outperform’, citing sale potential.
Davy lifted its recommendation on the shares from ‘neutral’, arguing that the company is a target for a trade sale.
Davy said a capital raise seems less likely than a sale, which is an outcome pre-IPO shareholders will likely make a push toward.
Davy maintained its 30p price target on the shares, which by 1255 BST, were trading up 11.5% at 8.81p.
(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector. "We are positive on sector fundamentals but see 2024 headwinds: a relative scarcity of big catalysts, US...
(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...
(Sharecast News) - Citi has lifted its target price for data analytics and consumer credit reporting group Experian after a near-30% jump in the stock in the past two months, but has maintained a 'neutral' rating on the stock. Citi said back in August that while US...
Subscribe to our mailing list to receive regular updates!
